|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weigelt B, Hu Z, He X, Livasy C, Carey LA,
Ewend MG, Glas AM, Perou CM and Van't Veer LJ: Molecular portraits
and 70-gene prognosis signature are preserved throughout the
metastatic process of breast cancer. Cancer Res. 65:9155–9158.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S and Kim VN: The nuclear RNase
III Drosha initiates microRNA processing. Nature. 425:415–419.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang W, Zhu J, Su S, Wu W, Liu Q, Su F and
Yu F: MiR-27 as a prognostic marker for breast cancer progression
and patient survival. PLoS One. 7:e517022012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Z, Liu S, Shi R and Zhao G: miR-27
promotes human gastric cancer cell metastasis by inducing
epithelial-to-mesenchymal transition. Cancer Genet. 204:486–491.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tanaka K, Miyata H, Sugimura K, Fukuda S,
Kanemura T, Yamashita K, Miyazaki Y, Takahashi T, Kurokawa Y,
Yamasaki M, et al: miR-27 is associated with chemoresistance in
esophageal cancer through transformation of normal fibroblasts to
cancer-associated fibroblasts. Carcinogenesis. 36:894–903. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu W, Qian K, Wei X, Deng H, Zhao B, Chen
Q, Zhang J and Liu H: miR27a promotes proliferation, migration, and
invasion of colorectal cancer by targeting FAM172A and acts as a
diagnostic and prognostic biomarker. Oncol Rep. 37:3554–3564. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang R, Xu J, Zhao J and Bai J: Knockdown
of miR-27a sensitizes colorectal cancer stem cells to TRAIL by
promoting the formation of Apaf-1-caspase-9 complex. Oncotarget.
8:45213–45223. 2017.PubMed/NCBI
|
|
13
|
Sun YP, Lu F, Han XY, Ji M, Zhou Y, Zhang
AM, Wang HC, Ma DX and Ji CY: MiR-424 and miR-27a increase TRAIL
sensitivity of acute myeloid leukemia by targeting PLAG1.
Oncotarget. 7:25276–25290. 2016.PubMed/NCBI
|
|
14
|
Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang
Y, Gu Q, Dong X, Liu F, Zhang Y and Li X: miR-27a-3p suppresses
tumor metastasis and VM by down-regulating VE-cadherin expression
and inhibiting EMT: An essential role for Twist-1 in HCC. Sci Rep.
6:230912016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Welcker M and Clurman BE: FBW7 ubiquitin
ligase: A tumour suppressor at the crossroads of cell division,
growth and differentiation. Nat Rev Cancer. 8:83–93. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mao JH, Kim IJ, Wu D, Climent J, Kang HC,
DelRosario R and Balmain A: FBXW7 targets mTOR for degradation and
cooperates with PTEN in tumor suppression. Science. 321:1499–1502.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wertz IE, Kusam S, Lam C, Okamoto T,
Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu J, et al:
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1
and FBW7. Nature. 471:110–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cardozo T and Pagano M: The SCF ubiquitin
ligase: Insights into a molecular machine. Nat Rev Mol Cell Biol.
5:739–751. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng Y and Li G: Role of the ubiquitin
ligase Fbw7 in cancer progression. Cancer Metastasis Rev. 31:75–87.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cai Y, Zhang M, Qiu X, Wang B, Fu Y, Zeng
J, Bai J and Yang G: Upregulation of FBXW7 suppresses renal cancer
metastasis and epithelial mesenchymal transition. Dis Markers.
2017:82769392017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li H, Wang Z, Zhang W, Qian K, Xu W and
Zhang S: Fbxw7 regulates tumor apoptosis, growth arrest and the
epithelial-to-mesenchymal transition in part through the RhoA
signaling pathway in gastric cancer. Cancer Lett. 370:39–55. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Zhang X, Ye M, Jing P, Xiong J,
Han Z, Kong J, Li M, Lai X, Chang N, et al: FBW7 loss promotes
epithelial-to-mesenchymal transition in non-small cell lung cancer
through the stabilization of Snail protein. Cancer Lett. 419:75–83.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li R, Wu S, Chen X, Xu H, Teng P and Li W:
miR-223/FBW7 axis regulates doxorubicin sensitivity through
epithelial mesenchymal transition in non-small cell lung cancer. Am
J Transl Res. 8:2512–2524. 2016.PubMed/NCBI
|
|
24
|
Tan Y, Sangfelt O and Spruck C: The
Fbxw7/hCdc4 tumor suppressor in human cancer. Cancer Lett.
271:1–12. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu XZ, Wang KP, Song HJ, Xia JH, Jiang Y
and Wang YL: MiR-27a-3p promotes esophageal cancer cell
proliferation via F-box and WD repeat domain-containing 7 (FBXW7)
suppression. Int J Clin Exp Med. 8:15556–15562. 2015.PubMed/NCBI
|
|
29
|
Pichler M, Stiegelbauer V,
Vychytilova-Faltejskova P, Ivan C, Ling H, Winter E, Zhang X,
Goblirsch M, Wulf-Goldenberg A, Ohtsuka M, et al: Genome-wide miRNA
analysis identifies miR-188-3p as a novel prognostic marker and
molecular factor involved in colorectal carcinogenesis. Clin cancer
Res. 23:1323–1333. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen MW, Yang ST, Chien MH, Hua KT, Wu CJ,
Hsiao SM, Lin H, Hsiao M, Su JL and Wei LH: The STAT3-miRNA-92-Wnt
signaling pathway regulates spheroid formation and malignant
progression in ovarian cancer. Cancer Res. 77:1955–1967. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rokavec M, Horst D and Hermeking H:
Cellular model of colon cancer progression reveals signatures of
mRNAs, miRNA, lncRNAs, and epigenetic modifications associated with
metastasis. Cancer Res. 77:1854–1867. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y, Ou Z, Sun Y, Yeh S, Wang X, Long J
and Chang C: Androgen receptor promotes melanoma metastasis via
altering the miRNA-539-3p/USP13/MITF/AXL signals. Oncogene.
36:1644–1654. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zare M, Bastami M, Solali S and Alivand
MR: Aberrant miRNA promoter methylation and EMT-involving miRNAs in
breast cancer metastasis: Diagnosis and therapeutic implications. J
Cell Physiol. 233:3729–3744. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chae DK, Ban E, Yoo YS, Kim EE, Baik JH
and Song EJ: MIR-27a regulates the TGF-β signaling pathway by
targeting SMAD2 and SMAD4 in lung cancer. Mol Carcinog.
56:1992–1998. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li J, Wang Y, Song Y, Fu Z and Yu W:
miR-27a regulates cisplatin resistance and metastasis by targeting
RKIP in human lung adenocarcinoma cells. Mol Cancer. 13:1932014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ren YQ, Fu F and Han J: MiR-27a modulates
radiosensitivity of triple-negative breast cancer (TNBC) cells by
targeting CDC27. Med Sci Monit. 21:1297–1303. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tang W, Yu F, Yao H, Cui X, Jiao Y, Lin L,
Chen J, Yin D, Song E and Liu Q: miR-27a regulates endothelial
differentiation of breast cancer stem like cells. Oncogene.
33:2629–2638. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao W, Zhang X, Liu J, Sun B, Tang H and
Zhang H: miR-27a-mediated antiproliferative effects of metformin on
the breast cancer cell line MCF-7. Oncol Rep. 36:3691–3699. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou S, Huang Q, Zheng S, Lin K, You J and
Zhang X: miR-27a regulates the sensitivity of breast cancer cells
to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis. Tumour Biol.
37:6837–6845. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kong LY, Xue M, Zhang QC and Su CF: In
vivo and in vitro effects of microRNA-27a on proliferation,
migration and invasion of breast cancer cells through targeting of
SFRP1 gene via Wnt/β-catenin signaling pathway. Oncotarget.
8:15507–15519. 2017. View Article : Google Scholar : PubMed/NCBI
|
